M
M. Viaggi
Researcher at University of Buenos Aires
Publications - 6
Citations - 36
M. Viaggi is an academic researcher from University of Buenos Aires. The author has contributed to research in topics: In vivo & Thyroid. The author has an hindex of 3, co-authored 6 publications receiving 33 citations.
Papers
More filters
Journal ArticleDOI
Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
M. Viaggi,M.A Dagrosa,Juan Longhino,Herman Blaumann,Osvaldo Calzetta,Stephen B. Kahl,G.J. Juvenal,Mario A. Pisarev +7 more
TL;DR: Only in mice treated with the neutron beam and injected with the boronated compounds the authors observed a 100% control of tumor growth, and no further improvement in the outcome was found compared to the previous results using BPA alone.
Journal ArticleDOI
Biodistribution of p-borophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC).
M.A Dagrosa,M. Viaggi,R. Jiménez Rebagliati,Víctor Castillo,D Batistoni,Rómulo L. Cabrini,S.G Castiglia,G.J Juvenal,Mario A. Pisarev +8 more
TL;DR: The selective uptake of BPA by spontaneous UTC in dogs is confirmed and plans to apply BNCT to mice in the future are planned.
Journal ArticleDOI
Nicotinamide increases thyroid radiosensitivity by stimulating nitric oxide synthase expression and the generation of organic peroxides.
M. Agote Robertson,P. Finochietto,C. A. Gamba,M.A Dagrosa,M. Viaggi,Maria Clara Franco,Juan José Poderoso,G. J. Juvenal,Mario A. Pisarev +8 more
TL;DR: Differentiated thyroid cancer and hyperthyroidism are treated with radioiodine, but when the radioisotope dose exceeds certain limits, the patient must be hospitalized to avoid contact with people that would otherwise be exposed to radiation.
Journal ArticleDOI
In vitro and in vivo studies of99mTc IgG: A comparison between three labeling methods
TL;DR: The ratio between inflamed thigh to normal thigh was similar and independent of the method of labeling, and the properties of99mTc polyclonal antibody labeled by three different methods were assessed by in vitro and in vivo studies.
Journal ArticleDOI
Tumor Imaging with 99mTc-Labeled FC-5.01 Monoclonal Antibody Using a Single Step Labeling Method
M. M. Barrio,M. Viaggi,M. Donaldson,Paula Portela,Laura Bover,José Mordoh,S. G. de Castiglia +6 more
TL;DR: Good and specific in vivo tumor targeting was demonstrated in nude mice bearing IIB-BR-G breast cancer xenografts and quality control tests demonstrated that the kit was stable for up to 120 days.